Notícias Acurx Pharmaceuticals Inc - ACXP | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Acurx Pharmaceuticals Inc (ACXP)
Acurx Pharmaceuticals Inc (ACXP) Notícias

Acurx Pharmaceuticals Inc (ACXP)

0,759

0,029

(3,97%)

Fechado 31 Janeiro 6:00PM

Atrasado por 15 minutos

0,73

-0,029

(-3,82%)

Após o horário de negociação: 9:28PM

Atrasado por 15 minutos

Discussões em tempo real e ideias de negociação: Negocie com confiança com nossa poderosa plataforma.

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Acurx Pharmaceuticals, Inc. Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form 8-K - Current report

Acurx Pharmaceuticals, Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Form 424B3 - Prospectus [Rule 424(b)(3)]

Acurx Receives Positive Regulatory Guidance from EMA for Ibezapolstat Phase 3 Program for C. Difficile Infection (CDI)

Acurx Updates Phase 3 Readiness for Ibezapolstat in C. difficile Infection Based on Recent FDA and EMA Communications

Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset

Form 8-K - Current report

Acurx Pharmaceuticals, Inc. Reports Third Quarter 2024 Results and Provides Business Update

Acurx Announces New Bile Acid and Microbiome Analyses from Ph2b Trial of Ibezapolstat in CDI Patients Presented at IDWeek Scientific Conference

Acurx Pharmaceuticals Announces Participation at The Spartan Capital Investor Conference to Showcase Growth Companies and Foster High-Level Investor Engagement

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Acurx Pharmaceuticals

FT Vest US Equity Deep B...

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições